More News
27 September 2018
Cellular Biomedicine Group Enters Into Strategic Licensing and Collaboration Agreement with a Global Leader in CAR-T Cell Therapy for Patients in China26 September 2018
Alexion to Acquire Syntimmune26 September 2018
Cerecor to Acquire Ichorion Therapeutics21 September 2018
Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders19 September 2018
Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy19 September 2018
Integral Molecular Partners with Merus to Discover Novel Therapeutic Monoclonal Antibodies18 September 2018
Samumed And United Therapeutics Announce North American License Agreement For Samumed’s IPF Drug Candidate18 September 2018
MorphoSys and LEO Pharma Expand Strategic Alliance to Develop Peptide-derived Therapeutics17 September 2018
ITM and Merck KGaA Sign Research Evaluation and Option Agreement to Develop Folate Receptor Targeted Radionuclide Therapy17 September 2018
CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes15 September 2018
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline14 September 2018
Supernus to Acquire Biscayne Neurotherapeutics13 September 2018
Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies13 September 2018
Gilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing8 September 2018
CYTOO enters into Research and Option Agreement with Pfizer to develop a target discovery platform for Duchenne Muscular Dystrophy6 September 2018
Atara Biotherapeutics and Moffitt Cancer Center Announce Strategic Collaboration to Develop Next-Generation CAR T Immunotherapies5 September 2018
Biohaven Licenses Novel Myeloperoxidase Inhibitor From AstraZeneca: Potential First-In-Class Treatment For Multiple System AtrophyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports